Neonatal Intensive Care Unit Amikacin Dosage Protocol | Download Scientific Diagram
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Indian Guidelines on Nebulization Therapy - ScienceDirect
Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia | NEJM
Antibiotics | Free Full-Text | How to Use Nebulized Antibiotics in Severe Respiratory Infections
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia | Critical Care | Full Text
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
Full article: The role of amikacin in the treatment of nontuberculous mycobacterial disease
PDF) Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
MAC Resources | ARIKAYCE® (amikacin liposome inhalation suspension)
Mean cumulative systemic absorption of amikacin as a function of time.... | Download Scientific Diagram
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial | Semantic Scholar
PDF) Amikacin nebulization for the adjunctive therapy of gram-negative pneumonia in mechanically ventilated patients: a systematic review and meta-analysis of randomized controlled trials
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia | Critical Care | Full Text
Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects | Intensive Care Medicine
Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease | Antimicrobial Agents and Chemotherapy
Frontiers | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
Delivery Efficacy of a Vibrating Mesh Nebulizer and a Jet Nebulizer under Different Configurations | Journal of Aerosol Medicine and Pulmonary Drug Delivery
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia | Critical Care | Full Text